Aim: This retrospective study aimed to evaluate changes in body mass index (BMI) and haemoglobin A1c (HbA1c) levels among children and adolescents with type 1 diabetes mellitus (T1DM) transitioning from multiple daily injections (MDI) to insulin pump therapy over one year.
Methods: Data were collected from chart reviews of 33 T1DM patients. BMI z-scores were calculated using WHO charts, and HbA1c levels were recorded at pump initiation, 6 months, and 1 year thereafter.
Results: At pump initiation, mean HbA1c was 7.81% (95% CI: 7.49-8.12), improving to 7.41% (95% CI: 7.13-7.68) at 6 months (p=0.0068) and 7.42% (95% CI: 7.12-7.72) at 1 year (p=0.009). The initial BMI z-score was 0.65 (95% CI: 0.24-1.06), with a trend toward weight gain at 6 months (0.76, 95% CI: 0.45-1.26, p=0.097) but no significant change at 12 months (0.73, 95% CI: 0.34-1.12, p=0.377).
Conclusion: Insulin pump therapy significantly improved glycaemic control within 6 months and maintained it at 1 year, though BMI z-scores showed no significant change.
扫码关注我们
求助内容:
应助结果提醒方式:
